Croda, Inc.
Manufacturer of specialty ingredients and technologies for consumer care, life sciences (including pharmaceutical excipients and vaccine adjuvants), crop care and industrial applications. Operates global manufacturing and R&D sites, provides formulation and delivery-platform capabilities, and maintains sustainability and life-cycle assessment programmes.
Industries
N/A
Nr. of Employees
medium (51-250)
Patents
Products
Specialty ingredient portfolios
High-value ingredients intended to deliver targeted functional performance at low inclusion rates across personal care, homecare, fragrance, crop protection and pharmaceutical formulations.
Encapsulation and delivery systems
Delivery systems for controlled release and enhanced stability or performance of active ingredients in consumer and industrial applications, including biodegradable options.
Specialty ingredient portfolios
High-value ingredients intended to deliver targeted functional performance at low inclusion rates across personal care, homecare, fragrance, crop protection and pharmaceutical formulations.
Encapsulation and delivery systems
Delivery systems for controlled release and enhanced stability or performance of active ingredients in consumer and industrial applications, including biodegradable options.
Services
Laboratory and customer-facing formulation development, performance testing and technical assistance across consumer care, personal care, homecare, flavours and fragrances.
Supply and development of pharmaceutical-grade excipients, adjuvant systems and delivery materials to support vaccine and biologics formulation and scale-up.
Life cycle assessment, sustainability reporting and datapacks to quantify environmental impacts and support customer disclosure and product strategy.
Laboratory and customer-facing formulation development, performance testing and technical assistance across consumer care, personal care, homecare, flavours and fragrances.
Supply and development of pharmaceutical-grade excipients, adjuvant systems and delivery materials to support vaccine and biologics formulation and scale-up.
Life cycle assessment, sustainability reporting and datapacks to quantify environmental impacts and support customer disclosure and product strategy.
Expertise Areas
- Specialty ingredient manufacturing and scale-up
- Formulation development for consumer and industrial markets
- Pharmaceutical excipients and vaccine adjuvant development
- Delivery and encapsulation technologies
Key Technologies
- Encapsulation and controlled-release systems
- Lipid excipient synthesis
- Vaccine adjuvant formulation
- Biosurfactant production
News & Updates
Launch of a biodegradable version of an odour-neutralising ingredient for air care (product announcement).
Publication of an evidence-based white paper on regenerative agriculture and related innovations in crop care.
Release of new SPF-boosting performance data for a sun care ingredient.
Sales performance update for the three months ended 30 September 2025.
Announcement of expansion of a biopharma-refined facility to support higher-purity manufacturing.
Opening of a new lipids manufacturing facility in Lamar, Pennsylvania to increase production capacity.
Launch of a biodegradable version of an odour-neutralising ingredient for air care (product announcement).
Publication of an evidence-based white paper on regenerative agriculture and related innovations in crop care.
Release of new SPF-boosting performance data for a sun care ingredient.
Sales performance update for the three months ended 30 September 2025.
Announcement of expansion of a biopharma-refined facility to support higher-purity manufacturing.
Opening of a new lipids manufacturing facility in Lamar, Pennsylvania to increase production capacity.